Sanofi
IL-8 level based method of predicting the outcome of colon cancer treatment
Last updated:
Abstract:
The present invention concerns the use of interleukin-8 (IL-8) as a biomarker for predicting the outcome of the treatment with aflibercept, or ziv-aflibercept of a patient suspected to suffer from a cancer.
Status:
Grant
Type:
Utility
Filling date:
18 Jan 2017
Issue date:
10 Dec 2019